Barbara Curtis (Mc Elroy)
About Barbara Curtis (Mc Elroy)
Barbara Curtis (Mc Elroy) is a Senior Product Manager in Immuno-Oncology Marketing at Bristol Myers Squibb in Switzerland, with extensive experience in pharmaceutical sales and marketing.
Company
Barbara Curtis (Mc Elroy) currently works at Bristol Myers Squibb as the Senior Product Manager for Immuno-Oncology Marketing in Switzerland. Her role focuses on overseeing and managing the marketing strategies and initiatives within the Immuno-Oncology sector. She has played a key role in launching new cancer treatment indications and managing broader oncology portfolios.
Title
Barbara Curtis (Mc Elroy) holds the position of Senior Product Manager - Immuno-Oncology Marketing at Bristol Myers Squibb. Her responsibilities include leading marketing strategies, launching new product indications, and contributing to the development and management of the Immuno-Oncology portfolio. She is based in Switzerland.
Education and Expertise
Barbara Curtis (Mc Elroy) has a strong educational background, having studied at William & Mary for her undergraduate degree, where she focused on Government, Philosophy, and French, earning a Bachelor of Arts (B.A.). She also completed a Master of Business Administration (MBA) from the William & Mary – Raymond A. Mason School of Business between 2001 and 2005. Barbara’s expertise lies in pharmaceutical sales and marketing, with extensive experience in both fields.
Career Background
Barbara Curtis (Mc Elroy) brings a wealth of experience from her previous roles. She co-founded Home Republic in Virginia Beach, VA, where she worked from 2014 to 2021. Prior to that, she spent 10 years at Boehringer Ingelheim as a Specialty Sales Territory Manager for Cardiovascular in the Hampton Roads and Richmond territories from 2007 to 2017. Her career has been marked by successful leadership and strategic initiatives in the pharmaceutical industry.
Achievements in Immuno-Oncology Marketing
Barbara Curtis (Mc Elroy) has achieved notable accomplishments in her current role at Bristol Myers Squibb. She led the launch of a bladder cancer indication while managing the broader Immuno-Oncology portfolio. In recognition of her contributions to the field, she was honored as a 2021 HBA Rising Star. Additionally, she participated in the Commercial Leadership Development Program, focusing on empathetic leadership, further honing her skills in pharmaceutical marketing and leadership.